Table 5. Pre-test and post-test MVC electromyographic (EMG: mV) activity over the six conditions. There were no significant main effcts or interactions.
|
PF IPSI |
PF CONTRA |
PF Control |
| Soleus pre-test |
0.30 ± 0.10 |
0.27 ± 0.16 |
0.23 ± 0.11 |
| Soleus post-test |
0.25 ± 0.11 |
0.27 ± 0.15 |
0.25 ± 0.18 |
| Gastrocnemius pre-test |
0.26 ± 0.15 |
0.26 ± 0.12 |
0.22 ± 0.15 |
| Gastrocnemius Post-test |
0.21 ± 0.17 |
0.27 ± 0.17 |
0.23 ± 0.16 |
| Biceps Brachii pre-test |
0.78 ± 0.38 |
0.78 ± 0.41 |
0.74 ± 0.35 |
| Biceps brachii post-test |
0.74 ± 0.41 |
0.74 ± 0.42 |
0.78 ± 0.45 |
| Triceps brachii pre-test |
0.08 ± 0.03 |
0.08 ± 0.03 |
0.079 ± 0.02 |
| Triceps brachii post-test |
0.07 ± 0.03 |
0.08 ± 0.03 |
0.076 ± 0.02 |
